课题基金 / 基金详情

A PHASE II, RANDOMIZED TRIAL OF AMPHOTERICIN B ALONE OR COMBINED WITH FLUCONA

A PHASE II, RANDOMIZED TRIAL OF AMPHOTERICIN B ALONE OR COMBINED WITH FLUCONA
单独使用两性霉素 B 或与 FLUCONA 联合使用的 II 期随机试验
批准号:
7603915
负责人:
ROBERT A LARSEN
金额:
$43.67万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

ROBERT A LARSEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study proposes to evaluate amphotericin B alone or combined with fluconazle in the treatment of AIDS-associated cryptococcal meningitis. This is a multi-national, phase II randomized trial in which subjects will be recruited from multiple sites in both the US and Thailand. 10 subjects will be tested and monitored here at USC. The trial requires a period of infusion, a period of ingestion by mouth, and a follow-up period. All study procedures will be performed in the GCRC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PHASE II, RANDOMIZED TRIAL OF AMPHOTERICIN B ALONE OR COMBINED WITH FLUCONA
CALIFORNIA NEUROAIDS TISSUE NETWORK (AIDS)
CALIFORNIA NEUROAIDS TISSUE NETWORK (AIDS)
Antifungal Drug Susceptibility of Cryptococcus neoformans
海外基金